Rafael Palmeiro

Wait, someone has evidence that Rafael Palmeiro really was clean and is unwilling to do anything about it?

56 Comments

John Perrotto of Baseball Prospectus has a Hall of Fame vote and has published a Hall of Fame column, and boy howdy does it have an interesting passage in it regarding Rafael Palmeiro, for whom he is voting:

Rafael Palmeiro: An extremely reliable source—with no ties to Palmeiro—told me an off-the-record story at the Winter Meetings that convinced me that Palmeiro was indeed a clean player and was tricked into using the steroid when he thought he was taking a shot of vitamin B-12 that led to his suspension and end of his career in 2005. Unfortunately, there would be too many legal ramifications to make the story public.

“Legal ramifications?” That’s … interesting. Normally I’d dismiss such stuff out of hand because it’s all so he-said, she-said sounding. But it is probably worth noting that, in Maryland, where Palmeiro was playing at the time of his positive PED test, there is no statute of limitations for felonies so, yes, someone may very well be worried about legal ramifications for assault or whatever you could think to classify drugging someone without their knowledge or consent.

Not that I’m prepared to actually buy this. After all, are we truly to believe that Rafael Palmeiro possesses convincing evidence that one of his teammates (or trainers or whoever) doped him, ending his career, ruining his legacy and putting him at risk of criminal prosecution for lying to Congress and yet Palmeiro is unwilling to say anything about it publicly? The man has became a disgrace and a laughingstock as a result of that positive test. The poster boy for lying cheaters, thanks to that finger-wag while under oath.  Is it reasonable, then, to assume that he has no incentive to clear his name with the convincing story Perrotto was told? He’s worried about someone getting in some relatively minor criminal trouble and is willing to wear the goat horns the rest of his life because of it?

Or I suppose maybe he doesn’t know. In that case, there is apparently someone working in baseball — the guy was at the Winter Meetings after all — with evidence that would clear Palmeiro’s name, yet rather than bring it to anyone’s attention who could do something about it, is simply telling to baseball writers, off the record, over drinks at the lobby bar in the Opryland Hotel. What kind of a person is that?

I don’t know. It all sounds like far-fetched bar talk. I can say this much, though: if there is any truth to this, it brings us back to the old dynamic of the PED story in baseball: people, including writers, knowing what’s really going on, yet no one being all that interested in exposing it. How very shameful. And, in some ways, how very appropriate.

Jacob deGrom open to extension with Mets

New York Mets starting pitcher Jacob deGrom talks during media day for the Major League Baseball World Series against the Kansas City Royals Monday, Oct. 26, 2015, in Kansas City, Mo. (AP Photo/Charlie Riedel)
AP Photo/Charlie Riedel
1 Comment

The Mets are currently enjoying the spoils of the best young rotation in the game, but the big question is whether this is just a brief window or the start of sustained success. Given the huge prices on the free agent market, it’s going to be next to impossible to keep the band together, but at least one member of the rotation is open to sticking around for the long-term.

While there haven’t been any talks yet, All-Star right-hander Jacob deGrom told Kevin Kernan of the New York Post that he could see himself discussing an extension with the Mets.

“I’m a little bit older, so I might be more willing to do something like that,’’ deGrom told The Post at Mets pre-camp. “You just have to look at what is fair so both sides get a decent deal. It’s something I’d have to look into and make sure I agree with it.’’

It makes sense from deGrom’s perspective. He broke into the majors later than most prospects, so he’ll be 28 this June. Depending on whether he qualifies as a Super Two, he’ll be arbitration-eligible for the first time after either 2016 or 2017. Either way, he’s under team control through 2020, which means that he’s currently on track to hit free agency after his age-32 season. The market might not be kind to him even if he manages to stay healthy, so it could behoove him to get as much guaranteed money as possible right now. The Mets could always decide to play things year-to-year, but perhaps deGrom would be willing to settle for a discount in order to get them to buy out a free agent year or two. It’s a really interesting situation to think about, but odds are the two sides will wait on contract talks until he’s arbitration-eligible for the first time.

DeGrom owns a 2.61 ERA in 52 starts over his first two seasons in the majors. Among starters, only Zack Greinke, Jake Arrieta, and Clayton Kershaw have a lower ERA since the start of 2014.

Royals, Mike Moustakas avoid arbitration with two-year deal

Kansas City Royals' Mike Moustakas celebrates after hitting an RBI single against the Toronto Blue Jays during the eighth inning in Game 2 of baseball's American League Championship Seriesagainst the Toronto Blue Jays  on Saturday, Oct. 17, 2015, in Kansas City, Mo. (Nathan Denette/The Canadian Press via AP) MANDATORY CREDIT
Nathan Denette/The Canadian Press via AP
1 Comment

The Royals and third baseman Mike Moustakas have avoided arbitration by agreeing to a two-year, $14.3 million deal, reports Jon Heyman of MLB Network.

The deal, which was initially discussed last month, buys out Moustakas’ final two years of arbitration. Jeffrey Flanagan of MLB.com reports that it’s believed he’ll make $5.6 million in 2016 and $8.7 million in 2017.

The 27-year-old Moustakas posted an underwhelming .668 OPS over his first four seasons in the majors, but he enjoyed a big postseason in 2014 before breaking out last season by batting .284/.348/.470 with 22 home runs and 82 RBI.

Report: Rays having “advanced talks” with free agent reliever Tommy Hunter

Baltimore Orioles relief pitcher Tommy Hunter throws to the Miami Marlins during the seventh inning of a baseball game in Miami, Friday, May 22, 2015. (AP Photo/J Pat Carter)
AP Photo/J Pat Carter
Leave a comment

ESPN’s Jerry Crasnick reported this morning that free agent reliever Tommy Hunter required core muscle repair surgery earlier this offseason. Coming off a disappointing 2015, it’s understandable why he’s still on the market, but it sounds like he has at least one significant lead.

Marc Topkin of the Tampa Bay Times hears that the Rays are having “advanced talks” with Hunter as they attempt to add an experienced arm to their bullpen. Nothing is considered close and Hunter is also talking to other clubs. Meanwhile, the Rays have been in touch with veteran reliever Ryan Webb while monitoring the trade market.

Hunter posted a 2.88 ERA as a late-inning arm from 2013-2014, but he compiled a mediocre 4.18 ERA over 58 appearances last season between the Orioles and Cubs. On the bright side, his velocity has held steady and his control is still very good. Despite the down year and core muscle surgery, Topkin writes that Hunter may be holding out for a multi-year deal.

Pirates sign left-hander Cory Luebke

Cory Luebke Getty
Photo by Doug Pensinger/Getty Images
Leave a comment

Eric O'Flaherty wasn’t the only reclamation project added by the Pirates today, as the club also announced that they have signed left-hander Cory Luebke to a minor league contract with an invitation to spring training.

Luebke once looked like a solid rotation piece for the Padres, but he hasn’t thrown a pitch in the majors since April 27, 2012. He’s undergone a pair of Tommy John surgeries since. Now 30 years old, he logged seven innings in the minors last season before requiring a procedure to remove loose bodies around a nerve in his forearm. The Padres cut ties with him in November after declining a $7.5 million club option for 2016.

It’s hard to count on much from Luebke at this point, but he told Adam Berry of MLB.com that he feels healthy and hopes to compete for a bullpen job in the spring.